These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2886888)

  • 1. Comparison of the butyrate effects on neurotransmitter receptors in neurohybrids NG108-15 and NCB-20 cells.
    Zhu XZ; Chuang DM
    Life Sci; 1987 Aug; 41(9):1133-9. PubMed ID: 2886888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation by butyrate and dibutyryl cyclic AMP of delta-opioid, alpha 2-adrenergic, and muscarinic cholinergic receptors in NCB-20 cells.
    Zhu XZ; Chuang DM
    J Neurochem; 1988 Jan; 50(1):17-26. PubMed ID: 2826684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
    Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
    Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous up-regulation of Ni-coupled receptors in cultured neural hybrid cells by a transferable factor, whose expression is inhibited in a cyclic AMP-dependent, cell-specific manner.
    Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
    Mol Pharmacol; 1987 Nov; 32(5):669-77. PubMed ID: 2824982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone.
    Belcheva MM; Barg J; McHale RJ; Gao XM; Chuang DM; Coscia CJ
    J Pharmacol Exp Ther; 1991 Oct; 259(1):302-9. PubMed ID: 1656025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of butyrate and dibutyryl cAMP on mRNA levels of muscarinic acetylcholine receptor subtypes expressed in neurohybrid cell lines.
    Fukamauchi F; Mataga N; Wang YJ; Chuang DM
    Neurosci Lett; 1996 Jul; 212(1):49-52. PubMed ID: 8823760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of receptor-mediated inhibition of adenylate cyclase in NG108-15 neuroblastoma X glioma cells by n-ethylmaleimide.
    Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Feb; 228(2):425-33. PubMed ID: 6319678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enkephalin and alpha-adrenergic receptors: evidence for both common and differentiable regulatory pathways and down-regulation of the enkephalin receptor.
    Simantov R; Baram D; Levy R; Nadler H
    Life Sci; 1982 Sep 20-27; 31(12-13):1323-6. PubMed ID: 6292623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of clonidine and clonidine analogues with alpha-adrenergic receptors of neuroblastoma X glioma hybrid cells and rat brain: comparison of ligand binding with inhibition of adenylate cyclase.
    Atlas D; Sabol SL
    Eur J Biochem; 1981 Jan; 113(3):521-9. PubMed ID: 6260485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-mediated inhibitions of NG108-15 adenylate cyclase: essential role of Na+ and GTP.
    Blume AJ; Lichtshtein D; Boone G
    Adv Biochem Psychopharmacol; 1980; 21():339-48. PubMed ID: 6246750
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of functional beta-adrenergic receptors in rat aortic smooth muscle cells by sodium butyrate.
    Nambi P; Whitman MH; Schmidt DB; Heckman GD; Stassen FL; Crooke ST
    Biochem Pharmacol; 1986 Nov; 35(21):3813-20. PubMed ID: 3022740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-induced down-regulation of muscarinic cholinergic and alpha 2-adrenergic receptors after inactivation of Ni by pertussis toxin.
    Thomas JM; Hoffman BB
    Endocrinology; 1986 Sep; 119(3):1305-14. PubMed ID: 2426098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of opioid receptor activity by phorbol esters in neuroblastoma x glioma NG108-15 hybrid cells.
    Louie AK; Bass ES; Zhan J; Law PY; Loh HH
    J Pharmacol Exp Ther; 1990 Apr; 253(1):401-7. PubMed ID: 2158550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cycloheximide and tunicamycin on opiate receptor activities in neuroblastoma X glioma NG108-15 hybrid cells.
    Law PY; Ungar HG; Hom DS; Loh HH
    Biochem Pharmacol; 1985 Jan; 34(1):9-17. PubMed ID: 2981531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
    Kushner L; Zukin SR; Zukin RS
    Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
    Evans T; Smith MM; Tanner LI; Harden TK
    Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic approach to reveal the action of the opiate receptor in selected neuroblastoma-glioma cells. Interaction with alpha-adrenoceptors, calmodulin and Ca2+-ATPase.
    Simantov R; Nadler H; Levy R
    Eur J Biochem; 1982 Nov; 128(2-3):461-6. PubMed ID: 6295758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium butyrate induces pyroglutamyl peptidase I and decreases thyrotropin-releasing hormone receptors in GH3 cells.
    Suen CS; Wilk S
    Endocrinology; 1989 Apr; 124(4):1654-60. PubMed ID: 2564336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.